The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether a patient's memory problems are likely caused by Alzheimer's disease . The new test, called Elecsys pTau181, was developed by Roche Diagnostics in partnership with Eli Lilly . It's designed for adults 55 and older who are showing early signs of cognitive decline. "By bringing Alzheimer's blood-based biomarker testing into primary care, we can help patients and their clinicians get

Tag-uri: Roche